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04 The Journal of Thoracic and Cardiobjectives: Mediastinal radiation for thoracic malignancies uses multiple treatment
elds and doses. We investigated whether more extensive radiation exposure is
ssociated with more hospital complications and worse survival after cardiac surgery.
ethods: From January 2000 to January 2005, 230 patients underwent cardiac
urgery after 3 levels of mediastinal radiation: extensive (Hodgkin disease, thy-
oma, and testicular cancer; n  70), variable (eg, non-Hodgkin lymphoma and
ung cancer; n  35); and tangential (breast cancer; n  125). Hospital complica-
ions were recorded prospectively, and time-related survival was assessed by patient
ollow-up (mean follow-up, 2.2  1.4 years).
esults: Patients receiving extensive exposure were youngest (51 vs 64 vs 72
ears), with the longest radiation-to-operation interval (25 vs 13 vs 14 years),
nd had the most diastolic dysfunction, left main stenosis of greater than 70%
21% vs 9% vs 8%), and aortic regurgitation (79% vs 54% vs 50%). Patients
eceiving extensive and variable exposure had the poorest pulmonary function
percent predicted forced expiratory volume in 1 second, 57% vs 54% vs 67%;
ercent predicted forced vital capacity, 56% vs 63% vs 66%). All groups
eceived a similar mix of cardiac procedures. Hospital deaths (13% vs 8.6% vs
.4%) and respiratory complications (24% vs 20% vs 9.6%) were higher after
ore extensive radiation, and survival was poorer (4-year survival, 64% vs 57% vs
0%) than for patients receiving tangential radiation exposure, and it deviated more
rom expected matched-population life tables.
onclusions: Among patients undergoing cardiac surgery after thoracic radiation,
adiation exposure is heterogeneous, and therefore these patients cannot be managed
nd assessed as a single uniform cohort. Extensively irradiated patients are more
ikely to develop radiation heart disease, which increases perioperative morbidity
nd decreases short- and long-term survival.
horacic radiation has been an effective treatment for cancers involving the
mediastinum and thorax. However, patients so treated might experience
subsequent cardiac disease and become candidates for cardiac surgery.1-3 It
as been observed that patients receiving radiation before cardiac surgery, as a
roup, have poorer short- and long-term outcomes than those not receiving radia-
ion.4-10 However, postradiation patients are a heterogeneous group in regard to the
echnique of radiation exposure and possibly in regard to the causation of their heart
isease. Past studies combined patients into a single group and did not assess the
ffect of treatment fields and radiation dosing on outcomes. We hypothesized that
atients receiving extensive thoracic radiation exposure have worse outcomes than
hose receiving less mediastinal exposure. Therefore we (1) contrasted patients, their
eart disease, and radiation-related comorbidities according to the extent of radia-
ion treatment; (2) characterized in-hospital complications and their risk factors; and
vascular Surgery ● February 2007
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CD3) assessed time-related mortality and its risk factors in
atients undergoing cardiac surgery after remote radiation
herapy.
atients and Methods
atients
rom January 2000 to January 2005, 15,074 cardiac operations
ere performed at Cleveland Clinic. Of these, 230 patients had
eceived previous thoracic radiation for treatment of malignancy.
rimary data were collected concurrently with patient care as part
f the Cardiovascular Information Registry. We reviewed each
atient’s medical records to identify type of cancer treatment,
ncluding combined chemoradiotherapy and extent and timing of
adiation. Expiration summaries and autopsy findings were re-
iewed to assign a mode of hospital death. Both Cardiovascular
nformation Registry data and data obtained from medical record
eview were preapproved for use in research by the institutional
eview board, such that patient consent was waived.
adiation Extent
he majority of patients underwent radiation for breast cancer
n  125, 55%), followed by Hodgkin disease (n  61, 27%),
on-Hodgkin lymphoma (n  12, 5.2%), lung cancer (n  15,
.5%), and other malignancies (testicular cancer, laryngeal cancer,
sophageal cancer, thymoma, leukemia, sarcoma, and pulmonary
ancer with unknown primary; n  17, 7.4%). Because exact
adiation treatment field and dose were usually unavailable, we
rouped patients into 3 categories according to presumed extent of
ardiac radiation. During the study period, radiation therapy for
odgkin disease, thymomas, and testicular cancer typically in-
luded extensive mediastinal radiation involving portions of the
eart (extensive radiation group). Patients with other thoracic
umors (non-Hodgkin lymphoma; lung, esophageal, and laryngeal
ancers; sarcoma; leukemia; and 1 pulmonary cancer with un-
nown primary) received varying doses of radiation to the medi-
stinum, heart, and surrounding structures (variable radiation
roup). Patients with breast cancer typically received peripheral
adiation to the breast or chest wall, with less direct exposure of
eart structures (tangential radiation group).
utcomes
arly in-hospital complications assessed included mortality, respi-
atory insufficiency, renal failure, stroke, myocardial infarction,
epsis, and reoperation for bleeding, as defined for the Society of
horacic Surgery National Database (Table E1).
Time-related survival was assessed by using Institutional Re-
iew Board–approved mailed or telephone questionnaires, with the
atient’s or a surviving family member’s consent. Circumstances
Abbreviations and Acronyms
FEV1  forced expiratory volume in 1 second
ITA  internal thoracic artery
LV  left ventricular
RV  right ventricularf death were elicited to the extent possible. The common closing u
The Journal of Thoracicate for vital status was July 20, 2004. Active follow-up was ampli-
ed when necessary by use of the Social Security Death Index,
hich was queried on January 20, 2005.11,12 Mean follow-up was
.2 1.4 years, with 505 patient-years of information available for
nalysis.
ata Analysis
Hospital events. Multivariable logistic regression was used to
dentify risk factors for postoperative events. Radiation extent and
umor type, demographics, symptoms, cardiac rhythm and func-
ion, details of the cardiac disease treated, noncardiac comorbidity,
emodynamics, and procedure variables were considered in the
nalysis (Table E2). Initial screening ensured that at least 5 events
ere associated with each candidate risk factor. Bootstrap bagging
as used for variable selection, with automated analysis of 500
esampled data sets with a P value of .05 or less for variable
nclusion, followed by tabulating frequency of occurrence of both
ingle factors and closely related clusters of factors.13,14 Variables
ith occurrence higher than 50% were considered reliably identi-
ed at a P value of .05 or less.
Survival. Survival was estimated nonparametrically by using
he Kaplan–Meier method and parametrically by using hazard
unction decomposition.15 It was compared with expected US
opulation survival matched for age, sex, and race. Multivariable
nalysis of death was performed in the hazard function domain,
sing bootstrap bagging for variable selection.15
resentation
ategoric variables are presented as frequencies and percentages.
ontinuous variables are summarized as means and standard de-
iations. Asymmetric 68% confidence limits are equivalent to 1
tandard error.
esults
adiation Extent
atients receiving extensive radiation were the youngest and
ad the longest interval between radiation treatment and
ardiac surgery, the highest preoperative central venous
ressures, the greatest diastolic dysfunction, the smallest
earts, and the highest prevalence of pericarditis, left main
oronary artery stenosis, and aortic regurgitation (Table 1). 16
he variable radiation group had the highest prevalence of
evere chronic obstructive pulmonary disease, smokers, and
enal insufficiency, with the highest preoperative creatinine
evel. Both groups had higher heart rates and pulmonary artery
iastolic pressures and were more likely than the tangential
roup to have ischemic mitral valve regurgitation. The tangen-
ial radiation group was composed entirely of women, who
ere the oldest patients and had the highest prevalence of
egenerative mitral valve disease and highest preoperative
redicted forced expiratory volume in 1 second (FEV1).
Operations performed were generally similar among the
roups (Table 2). Among patients with 50% or greater
tenosis of the left anterior descending coronary artery
ndergoing coronary artery bypass grafting (n  95), only
and Cardiovascular Surgery ● Volume 133, Number 2 405
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CD4 (46%) received internal thoracic artery (ITA) grafts, and
hese were similarly distributed among groups (P  .8).
n-hospital Complications and Their Risk Factors
here were 15 (6.5%) hospital deaths. The most frequent
ABLE 1. Patient characteristics
ariable
R
Extensive (n  7
emographics
Age (y) 51 13
Women 33 (47)
ancer-related comorbidity
Radiation to operation (y) 25 9.6
Chemotherapy* 36/51 (71)
emodynamics
Heart rate (beats · min1) 94  13
Cardiac index (L · min1 · min2) 2.7  0.89 (n 2
Central venous pressure (mm Hg) 13 5.0
PA diastolic pressure (mm Hg) 22 7.0
V structure and function
Diastolic dysfunction
None/abnormal relaxation (stage 1) 8 (30)
Pseudonormal (stage 2) 15 (56)
Restrictive (stage 3) 4 (15)
Restrictive-irreversible (stage 4) 0 (0)
Intraventricular septal thickness (cm) 1.1 0.25
Posterior wall thickness (cm) 1.03 0.25
Mass index (g · m2) 94  31
End-diastolic volume index (mL · m2) 54  22
Ejection fraction, echo (%) 49 14
ericardium
Pericarditis 13 (19)
oronary artery disease
Left main disease (50%) 19 (28)
alve disease
Aortic stenosis 34 (49)
Aortic regurgitation 55 (79)
Mitral stenosis 6 (9)
Mitral regurgitation 60 (86)
Ischemic*† 6/57 (11)
Degenerative* 18/57 (32)
Tricuspid regurgitation 52 (74)
ulmonary comorbidity
Severe COPD (%)‡ 6 (8.6)
Percent predicted FEV1 57  19 (n 27
Percent predicted FVC 56 19 (n 27
ther comorbidities
Tobacco use 35 (51)
Renal insufficiency 2 (2.9)
Creatinine (mg · dL1) 0.92 0.26
D, Standard deviation; PA, pulmonary artery; LV, left ventricular; COPD, chr
VC, forced vital capacity. *Because of incomplete information, denomina
atients having a documented prior myocardial infarction, with wall motion
Defined as FEV1 of less than 50%, room air PaO2 of less than 60%, or Paode of death was multisystem organ failure, often pre- 3
06 The Journal of Thoracic and Cardiovascular Surgery ● Febripitated by respiratory failure (Table 3). Hospital death
as higher in the extensive and variable radiation groups
han in the tangential group (Table 4); after adjusting for
ther factors, risk was highest in the extensive radiation
roup (P  .02, Table E3). These patients were nearly
ion extent, mean  SD or No. (% of n)
P valueVariable (n  35) Tangential (n  125)
64  12 72  8.8 .0001
12 (34) 125 (100) .0001
13  8.9 14  12 .0001
22/28 (79) 43/67 (64) .4
93  12 87  12 .0008
2.2 0.40 (n 12) 2.4 0.73 (n 43) .12
11  5.2 10  4.6 .006
22  7.7 20  7.1 .03
.0001
9 (53) 47 (87)
5 (29) 4 (74)
3 (17) 3 (5.6)
0 (0) 0 (0)
1.3 0.39 1.3 0.34 .001
1.06 0.22 1.16 0.24 .0007
120 46 118 41 .0003
62  21 55  24 .18
44  15 50  13 .2
2 (5.7) 6 (4.8) .004
6 (18) 19 (16) .12
12 (34) 58 (46) .4
19 (54) 63 (50) .0005
3 (8.6) 13 (10) .9
28 (80) 98 (78) .5
4/27 (15) 2/100 (2.0) .02
3/27 (11) 46/100 (46) .003
23 (66) 85 (68) .6
7 (20) 4 (3.2) .003
54 18 (n 11) 67 19 (n 40) .04
63 20 (n 11) 66 18 (n 40) .13
27 (77) 62 (50) .01
4 (11) 2 (1.6) .02
1.23 0.86 0.93 0.39 .03
bstructive pulmonary disease; FEV1, forced expiratory volume in 1 second;
shown. †Defined as at least moderate pure mitral valve regurgitation in
alies, and no gross mitral leaflet pathology or papillary muscle rupture.16
f greater than 50%.adiat
0)
3)
)
)
onic o
tor is
anom.5 times more likely to experience respiratory insuffi-
uary 2007
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A
CDiency (P  .006, Table E3). Intensive care unit and
ostoperative lengths of stay were similar among groups
Table 4).
ime-related Mortality and Its Risk Factors
t 1, 2, and 4 years postoperatively, unadjusted survival for
he tangential radiation group (88%, 84%, and 80% at 1, 2,
nd 4 years, respectively) was higher than that of the ex-
ABLE 2. Operation performed*
rocedure Extensive, n (% of 70) Var
ABG 36 (52)
TA use† 9/22 (41)
V replacement 39 (56)
V repair 5 (7.1)
V replacement 19 (27)
V repair 19 (27)
V replacement 0 (0)
V repair 11 (16)
ericardectomy 2 (2.9)
ortic surgery 5 (7.1)
eoperation 20 (29)
irculatory arrest 7 (10)
ABG, Coronary artery bypass grafting; ITA, internal thoracic artery; AV, a
xclusive. †In patients with 50% or greater stenosis of left anterior descend
ABLE 3. Modes of hospital death and autopsy findings
atient no. and
adiation extent Mode of death
xtensive
1 Sepsis, low cardiac output, respiratory failure, M
2 Mediastinitis, stroke, MSOF
3 Primary graft dysfunction after heart-lung transpl
4 Respiratory failure, MSOF
5 Respiratory failure commencing with pleural effu
6 Pneumonia, MSOF
7 Pneumonia
8 Pneumonia
9 Cardiac failure
ariable
1 Respiratory failure, MSOF
2 Cardiac failure, MSOF
3 Pneumonia, MSOF
angential
1 Respiratory failure, sternal dehiscence, MSOF
2 Cardiac arrest, anoxic encephalopathy
3 Respiratory arrest, mucous plugging, anoxic
encephalopathySOF, Multisystem organ failure.
The Journal of Thoracicensive (78%, 70%, and 64%) and variable (73%, 64%, and
7%) exposure groups (P  .003) and more nearly matched
xpected survival for the general population (Figure 1).
Both the extensive and variable radiation groups had
wice the adjusted risk of death of the tangential radiation
roup (Table 5), although the smaller number of patients
n the variable exposure group resulted in larger uncer-
ainty. In addition, patients with severe pulmonary or
tion extent
P value, n (% of 35) Tangential, n (% of 125)
2 (63) 69 (55) .5
9 (47) 26/54 (48) .8
5 (45) 56 (45) .3
0 (0) 1 (0.8) .02
7 (20) 23 (18) .4
9 (26) 26 (21) .6
0 (0) 3 (2.4) .7
3 (8.6) 19 (15) .6
2 (5.7) 2 (1.6) .4
2 (5.7) 12 (9.6) .7
3 (37) 25 (20) .09
1 (2.9) 9 (7.2) .4
valve; MV, mitral valve; TV, tricuspid valve. *Procedures are not mutually
oronary artery. Because of incomplete information, denominator is shown.
Autopsy findings
Bilateral pulmonary emboli, cirrhosis; bilateral pulmonary
congestion
Gram-negative suppurative mediastinitis; bilateral
pulmonary congestion, remote pulmonary embolus
ion
MSOF
Radiation pneumonitis with bilateral pneumonia
Remote and recent transmural and subendocardial left
ventricular infarctsRadia
iable
2
9/1
1
1
orticSOF
antat
sion,and Cardiovascular Surgery ● Volume 133, Number 2 407
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A
CDenal disease, lower hematocrit values, increased central
enous pressure, enlarged left atrium, smaller left ven-
ricular (LV) mass, or longer myocardial ischemic time
ere at higher risk of mortality (Table 5). Reoperation
er se was not identified as a risk factor, nor was use of
ypothermic circulatory arrest.
Of 39 deaths occurring after hospital discharge, mode of
eath could not be ascertained in 24. Of the remaining 15,
ode of death was cardiac related in 5, pulmonary related in
, renal failure in 1, multisystem organ failure in 1, and
ancer related in 3.
iscussion
horacic Radiation Exposure
ublished studies examining outcomes of cardiac surgery
fter thoracic radiation have not differentiated patients by
ntensity and fields of radiation received.4-10 This study
emonstrates the importance of this distinction.
Radiation groups were created according to generally
ccepted treatment approaches. In patients with thy-
oma, seminoma, and Hodgkin disease, radiation fields
t that time traditionally encompassed the entire medias-
inum (Figure E1).17-19 In contrast, breast cancer radia-
ion fields have been tangential to the base of the breast,
ith minimal exposure to the heart (Figure E2). The
emaining cancers in this study were included in the
ariable radiation group because of inhomogeneity of
adiation field design caused by tumor location and
volving historical changes in treatment approach.
rincipal Findings
n essence, patients receiving tangential radiation have
ardiac pathology and respond to surgical therapy like
onirradiated patients, and extensively and variably irra-
iated patients manifest cardiac injury that has been
ommonly referred to as radiation heart disease. The
ABLE 4. Postoperative in-hospital complications
omplication Extensive, n (% of 70)
ospital death 9 (13)
espiratory insufficiency 17 (24)
enal failure 6 (8.6)
epsis 9 (13)
troke 4 (5.7)
yocardial infarction 0 (0)
eoperation for bleeding 4 (5.7)
ternal wound infection* 3/67 (4.5)
CU length of stay (d)† 2 (1, 13)
ostoperative length of stay (d)† 8 (5, 36)
CU, Intensive care unit. *Denominator is number of patients having sternrominence of pulmonary dysfunction preoperatively and f
08 The Journal of Thoracic and Cardiovascular Surgery ● Febrarticularly postoperatively has led us to conclude that a
ore appropriate term is radiation heart and lung (car-
iopulmonary) disease.
The well-known microcirculatory injury caused by
adiation leads to an assortment of progressive cardiac
nd pulmonary pathologies, including pericarditis, peri-
ardial effusion, accelerated coronary artery arterioscle-
osis (especially ostial lesions), myocardial fibrosis,
alcification of the fibrous skeleton of the heart (ie,
adiation heart disease), pneumonitis, and lung fibro-
is.20-25 Fewer than 10% of our patients were diagnosed
s having pericarditis, and only 6 underwent pericardec-
omy, suggesting that constrictive pericarditis is an infre-
uent manifestation of radiation heart and lung disease.
Radiation heart disease produces heart failure symptoms
ith preserved LV function and is classified as a secondary
estrictive cardiomyopathy.26 Most of our patients had heart
ailure symptoms in the presence of normal LV function,
nd more extensively irradiated patients had higher central
enous pressures and pulmonary artery pressures, enlarged
eft atria, worse LV diastolic function, and lower LV end-
iastolic volume indices, all of which are consistent with
adiation heart disease. Conversely, the tangential group had
ore typical heart disease with simply a history of previous
adiation.
Radiation pulmonary injury results in restrictive lung
unction, which is found predominantly in extensively
rradiated patients, whereas variably irradiated patients
ere frequently smokers with moderate-to-severe
hronic obstructive pulmonary disease, and tangentially
xposed women had only mildly reduced FEV1 and
orced vital capacity, possibly related to kyphoscoliosis.
lthough smoking and musculoskeletal changes might
lay a role, radiation for Hodgkin disease and lung and
reast cancers is known to irreversibly impair pulmonary
Radiation extent
P valueVariable, n (% of 35) Tangential, n (% of 125)
3 (8.6) 3 (2.4) .01
7 (20) 12 (9.6) .02
5 (14) 4 (3.2) .04
5 (14) 10 (8.0) .4
0 (0) 1 (0.8) .06
1 (2.9) 0 (0) .15
3 (8.6) 9 (7.2) .8
1/34 (2.9) 4/122 (3.3) .9
2 (1, 21) 3 (1, 7) .36
9 (6, 29) 8 (6, 17) .9
y. †Median (15th, 85th percentiles).unction.27-31
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A
CDn-hospital Complications
ortality and morbidity were high in irradiated patients.
angentially irradiated patients fared best. Sternal wound
nfections were uncommon and occurred equally among the
radiation exposure groups, but prevalence was higher than
xpected among nonirradiated patients and unaffected by
se of the ITA.
Respiratory dysfunction, manifesting as pneumonia, in-
ractable pleural effusion, and reintubation for poor venti-
atory mechanics, was a frequent precursor to multisystem
rgan failure among our patients who died. There is likely
n important ongoing pulmonary debility that continues
ell after the cardiac disease has been palliated. This might
esult from a progressive decrease in chest wall compliance,
hrenic nerve and diaphragm dysfunction, intractable pleu-
al effusion, and possibly pulmonary fibrosis.
The exact role of radiation lung injury (found in 1 of 4
atients at autopsy) remains uncertain, but it appears that
educed preoperative pulmonary function (radiation or smok-
ng induced), decreased postoperative pulmonary mechanics,
nd pulmonary congestion (found in 2 of 4 patients at au-
opsy) caused by increased left atrial pressures from LV
iastolic dysfunction may partially explain early surgical
ortality and morbidity.
ime-related Survival
ore extensive thoracic radiation exposure was associated
ith poorer time-related survival that was substantially less
han that expected in the general population. The dose
ffect, risk factors for death, and paucity of cancer-related
eaths during follow-up suggest a causal link between both
ABLE 5. Incremental risk factors for death
isk factor Coefficient  SE
P
value
Reliability
(%)
adiation extent* 60
Extensive 0.74 0.35 .034
Variable 0.64  0.41 .12
igher central venous
pressure
0.050 0.023 .03 56
igher left atrial volume† 0.15 0.063 .02 46
ower left ventricular mass‡ 0.91 0.23 .0001 89
ower hematocrit§ 1.9 0.78 .02 63
evere COPD 0.90 0.40 .02 51
igher BUN 0.054 0.022 .02 68
onger myocardial ischemic
time¶
0.24 0.078 .002 60
E, Standard error; COPD, chronic obstructive pulmonary disease; BUN,
lood urea nitrogen. *Relative to tangential radiation. †Left atrial volume/
0, squared transformation. ‡Left ventricular mass/260, inverse transformation.
Hematocrit/40, inverse transformation. Blood urea nitrogen/20, squared
ransformation. ¶Myocardial ischemic time/80, squared transformation.igure 1. Survival after cardiac surgery in patients having prior
horacic radiation exposure. Each symbol represents a death,
ertical bars are 68% confidence limits representing 1 standard
rror, and numbers in parentheses represent patients alive and
eing traced. The solid line is the parametric estimate enclosed
ithin dashed confidence limits. The dash-dot-dash line is sur-
ival of the age-, race-, and sex-matched US population. A,
xtensive radiation group. B, Variable radiation group. C, Tan-
ential radiation group.ardiac and pulmonary radiation damage and prognosis.
and Cardiovascular Surgery ● Volume 133, Number 2 409
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A
CDHigh resting heart rate and the risk factor of small LV
ass together suggest that stroke volume is fixed, both
reoperatively and postoperatively, as a result of the restric-
ive cardiomyopathy. Increased central venous pressure as a
isk factor also suggests a component of right ventricular
RV) dysfunction. Few studies, ours included, have focused
pecifically on radiation effects on RV function. The result-
ng decrease in RV output leads to decreased LV preload in
atients already sensitive to filling conditions. Biventricular
ysfunction and diastolic heart failure could explain the
orse outcomes.
imitations
etails of cancer stage, radiation fields, and doses and
hemotherapy regimens were not available and might have
ltered our results. This was a single-institution study, but
panned a short interval during which patient selection
riteria and management strategies were rather uniform. We
ere unable to quantify LV diastolic dysfunction, although
n most patients it was graded qualitatively by echocardio-
raphers. We have no information about long-term progres-
ion of radiation effects on cardiac and pulmonary dysfunc-
ion after surgical intervention. Many times, it was not
ossible to elicit secure information about mode of late
eath, and there were few autopsies.
nferences About Clinical Management
Indications for operation. We use standard indications
or surgical intervention in these patients, but believe symp-
oms must be present before intervening. We could not
dentify hemodynamic or pulmonary function values below
hich successful conventional surgery would be precluded,
ut have recently questioned whether patients with multiple
ardiac problems, reduced RV or LV function, restrictive or
onstrictive hemodynamics, or undergoing reoperation
ight be better served by heart or heart-lung transplanta-
ion. A small series of patients undergoing transplantation
heds little light on this issue.32 Although at increased
ifetime risk of recurrent cancer, the few patients dying from
ancer during follow-up suggests that immunosuppression
ould be safe. However, incisional and bronchial or tra-
heal anastomotic healing might make this a less-than-ideal
olution.
Intraoperative management. Median sternotomy, thought
o be less morbid than a thoracotomy, may profoundly
mpair respiratory mechanics.33,34 Bauer and colleagues35
ound that 4 days after a ministernotomy or standard ster-
otomy, both FEV1 and forced vital capacity decreased by
0% from preoperative values and only slowly returned to
ormal. Thoracotomy is unlikely to be a better alternative.
ggressive preoperative smoking cessation, pulmonary re-
abilitation, and draining of pleural effusions might be
eneficial. Perhaps a thorough assessment of diaphragmatic Y
10 The Journal of Thoracic and Cardiovascular Surgery ● Februnction by means of fluoroscopic challenge (sniff test)
ould be of use to define high-risk patients.
During the study, most hearts were protected with cold,
lood-based antegrade and retrograde cardioplegia. This
ethod of myocardial protection, compared with antegrade-
nly or intermittent aortic clamping, has been associated
ith a decrease of early diastolic function in normal
earts.36 Use of hypothermia might also impair diastolic
ore than systolic function.37 Although it is impossible to
eparate the association of longer ischemic time with sicker
atients requiring more complex operations, the possibility
emains that irradiated hearts are more sensitive to ischemia,
ode of myocardial protection, and temperature, leading to
ncreased postoperative diastolic impairment. For patients
equiring isolated revascularization, off-pump procedures
ight be a better alternative.
At a minimum, cardiac operations need to be well
lanned and executed. This includes use of the ITA and
ften valve replacement. Infrequent use of the left ITA was
nanticipated; the primary authors have routinely used it.
lthough angiographic assessment of the ITA is used, it is
ot routine. Chest wall radiation for breast cancer does not
reclude use of either the right or left ITA. We acknowledge
he advantages of valve repair and lament the difficulties
osed by postoperative anticoagulation; however, like
anda and associates,4 we favor definitive therapy at the
nitial operation to reduce ischemic times and need for
eoperation.
Postoperative management. Because postoperative stroke
olume is invariably fixed, maintaining adequate cardiac
utput requires higher than usual filling pressures and heart
ates, with little benefit from inotropic therapy. Medical
egimens for diastolic heart failure, including -blockers,
ngiotensin-converting enzyme inhibitors, angiotensin re-
eptor blockade, diuretics, and aldosterone antagonists, are
imited and often ineffective. Use of a selective phosphodi-
sterase inhibitor III, such as milrinone, might be beneficial
ecause of positive lusitropic and pulmonary vasodilatory
roperties, bronchodilatory action, and increase of dia-
hragmatic contractility.
onclusions
e have demonstrated that extent of exposure among pa-
ients who have received thoracic radiation for cancer is
ariable, and therefore these patients cannot be managed
nd assessed as a single uniform cohort. Short- and long-
erm survival is diminished in those who are extensively
rradiated, and complications are frequent. Treating these
atients remains a great challenge; recent modifications in
adiation techniques might reduce future cardiac and pul-
onary injury.
We thank Songua Lin for statistical programming; Angelaork for database construction; Tanya Ashinhurst for registry
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oncurrently with patient care; and Tess Parry for editorial assis-
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iscussion
r Thoralf M. Sundt (Rochester, Minn). Well done, Dr Chang. A
ery nicely presented article. My colleagues and I from the other
linic share your concern about both the short- and long-term
utcomes of these patients. We are seeing more and more of these
olks, and it is really a tough population with which to deal. If I
nderstand your data correctly, given the choice from the menu of
adiation-treated patients on whom to operate, I should pick the
angential ones and leave the extensive ones to my junior col-
eagues. Unfortunately, most of the time, we have to deal with the
ases that we are served up, and accordingly, I have some specific
uestions for you that are perhaps more relevant as we face patient
y patient in the clinic.
With regard to the individuals having tangential radiation, you
entioned some of this in your article, which I appreciate you
and Cardiovascular Surgery ● Volume 133, Number 2 411
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CDending to me. Could you comment on the use of the ITA ipsilat-
ral to the radiation? I have quite frankly not used the ITA on the
ide of the radiation; this is almost an absolute rule for me. That is
robably the only population in which I do not use the ITA to the
eft anterior descending coronary artery, and I would like your
omments. What is your practice, and do you have any data about
ate ITA patency if the ITA has been irradiated?
A second question, focusing more on the patients receiving
xtensive radiation, who are the more problematic, you present
omething of a paradox. You argue for a definitive operation and
agree with that, the redo—as miserable as the first operation
s—the redo is really, really tough, and yet ischemic time was one
f the risk factors, so how do you balance that? What are your
ndications, for example? How much aortic regurgitation will you
olerate? When is the aortic regurgitation enough to warrant pro-
onging the ischemic time to subject the patient to an aortic valve
eplacement, which incidentally is a nontrivial exercise in these
atients?
How do you handle the mitral valve in these patients? Repair
ersus replacement—it can be a problem if they leak after a repair
nd you are faced with the challenge of whether to do a rerepair or
erform a transplantation. Pericardiectomy— how often did these
atients undergo pericardiectomy, and do you ever do a pro-
hylactic pericardiectomy? That is a frequent problem in these
adiation-treated patients.
Finally, with regard to your suggestion about transplantation,
hese patients are very tough as redos on the transplant list as well,
nd I wonder what guidelines you currently use to triage them up
ront. It seems we have an attitude today to give everybody a shot
ith a conventional operation and if that fails to refer them on to
ransplantation. As one of the transplant surgeons at my institution,
am a little bit more circumspect about that. The redo is really
npleasant for these.
Thank you very much, and I thank the association for the
pportunity to open the discussion on this article.
Dr Chang. Thank you, Dr. Sundt, for your comments and
uestions. In terms of internal thoracic artery use, we found that it
as used surprisingly less often than our normal coronary revas-
ularization practice pattern. In fact, barely half the eligible pa-
ients received an internal thoracic artery graft. We do no think
angential breast radiation precludes use of the internal thoracic
rtery. Studies from other institutions have shown conflicting
esults. Some authors state that despite radiation, the ipsilateral
nternal thoracic artery can be used, whereas others state that it
annot.
In terms of late patency, we have few angiographic studies, in
ommon with everybody else.
For the extensive patients, one must balance longer myocardial
schemic times against definitive operations. What we try to do is
im for a definitive operation. If the valve can be easily repaired,
e repair it. If there is any doubt, we believe replacement is the
est option. Thus, for example, we believe that a rapid definitive
peration is better than multiple pump runs in order to try to
alvage a leaking valve. Whether or not the longer myocardial
schemic time can be balanced out by the one-time definitive
peration has not yet been clarified.
Pericardectomy was performed in only 6 patients. Pericarditis
as present in less than 10% of patients. Thus, we do not perform p
12 The Journal of Thoracic and Cardiovascular Surgery ● Febrrophylactic pericardectomy. This does not seem to have been a
roblem, but it warrants careful follow-up.
In terms of transplantation, this was an issue brought up by Dr.
ytle recently. Although we usually try to give everyone a shot at
onventional surgery, we have been wondering if heart or heart–
ung transplantation might be better to avoid redo operations.
hese patients have already had radiation. They have had their
issue planes obliterated, and their tissues are not normal. Trying to
o an anastomosis, especially a bronchial or tracheal anastomosis,
n this radiated field can be challanging. Performing a redo oper-
tion on top of that would certainly make it a high-risk procedure.
e have not extended our practice pattern to going straight to
ransplantation, but it is something we are considering.
Currently, our indications for surgery are essentially the same
s for nonirradiated patients, although we prefer patients who are
ore symptomatic; we do not just look at their physiologic ab-
ormalities.
Dr James Mark (Stanford, Calif). Well done. Nice presenta-
ion. Dr Chang has brought an important problem to our attention
nd that is the aftermath of radiation to the chest. The patients to
hom he refers must have had chemotherapy as well, at least some
f them, and that treatment modality has its own problems. A few
eeks ago, Dr Saul Rosenberg, a senior medical oncologist at
tanford—that means he is as old as I am—gave a medical grand
ounds in which he reviewed the 45-year experience of the treat-
ent of Hodgkin disease at Stanford using first radiotherapy alone
nd then radiotherapy combined with chemotherapy. Their group,
pearheaded originally by Dr Henry Kaplan, who introduced the
inear accelerator into clinical use, has been religious in their
dherence to clinical trials and have found that by judicious
weaking of radiotherapy ports and dosages and by changing
hemotherapy combinations to include smaller doses of more
rugs, they can maintain a high tumor control rate while minimiz-
ng the side effects. For example, the present chemotherapy regi-
en includes small doses of 7 drugs in the treatment of Hodgkin
isease. Mediastinal complications such as we have heard about
oday are not the only deleterious effects of radiotherapy. We have
ll seen malignant tumors of the chest wall in radiated fields, and
he side effects of chemotherapy are too numerous and too diffuse
o even talk about today. Dr Chang tells us about a relatively short
ollow-up period, 2 years plus, in these patients. I know that the
leveland Clinic group will remain vigilant in looking for addi-
ional problems as time goes on. Some years ago, we reported an
ncrease in postoperative cardiac problems in patients who under-
ent preoperative radiation for lung cancer. Has Dr Chang studied
his group at all?
Thank you very much.
Dr Chang. Thank you, Dr. Mark. Stanford has been one of the
eaders in the treatment of Hodgkin disease. In our conclusions, we
lso have recognized that it is important to pay careful attention to
hat radiation fields have been used as well as what chemotherapy
reatments were given, as cancer treatments are constantly evolv-
ng. Over the last 20 years, treatment of Hodgkin disease, as Dr.
ark pointed out, has changed. It used to entail larger radiation
elds, but now involves less radiation and more chemotherapy.
ost of the patients in our study were treated about 20 years ago.
owever, 20 years from now or even 10 years from now, patients
resenting for cardiac surgery who have previously had treatment
uary 2007
f
m
k
h
i
b
t
C
c
g
t
r
g
e
r
t
g
a
p
t
i
c
o
t
d
i
t
a
m
p
a
s
a
a
t
p
a
o
h
t
a
w
s
Chang et al Surgery for Acquired Cardiovascular Disease
A
CDor Hodgkin disease will be different, and their extent of radiation
ay be different as well.
We do not have specific information on chemotherapy. We
now that about two-thirds to three-quarters of the patients did
ave chemotherapy, but because most were treated at outside
nstitutions, we did not have specific data.
We did not look specifically at lung cancer as a subgroup,
ecause only 15 patients had it. Rather, they were investigated in
he variable radiation group.
Dr Donald Low (Seattle, Wash). Dr. Chang, very good article.
learly the extensive and variable groups are at greatest risk for
omplications and outcomes, which are worse than seen in the
eneral population. With the experience you have just had, do you
hink the tangential radiation group is at any substantial increased
isk for complications, or is their risk equivalent to that of the
eneral population?
Dr Chang. That is a good point and one we were trying to
mphasize: Cardiac disease in the tangential group is most likely
elated to the natural history of conventional heart disease rather
han to the radiation itself. Those patients more closely match the
eneral population and probably should not be considered “radi-
tion heart disease” patients. They do have some changes in
ulmonary function, probably making them a slightly worse risk
han nonirradiated patients, because the lung is partially involved
n tangential radiation. These patients do have some pathologic t
The Journal of Thoracichanges in their lungs, but certainly minor compared with the two
ther groups.
Dr D. Craig Miller (Stanford, Calif). Nice work. I was
weaked by Dr Sundt’s question and heard your response that you
o not think much of parietal pericardiectomy the first time around
f you are going to embark on a conventional cardiac operation for
he extensive group. I share your group’s reticence and maybe we
re not doing the right thing here. We are kidding ourselves and
aybe transplantation in the suitable candidates—not all these
eople are with the radiation fibrosis to the lung and the esophagus
nd what not—but we have something that Stanford calls “Stin-
on’s rule,” which is probably not published, but it has been
round for 30 years. In this extensive group, with which we have
ll too much experience, Ed pointed out early, 20 or 25 years ago,
hat even though the parietal pericardium might look normal, it
robably is very wise to do a phrenic to phrenic pericardiectomy
nteriorly, at least the first time you are there, for left main disease
r AVR or mitral or whatever because these people come back and
aunt you badly. That is if you are going to embark on a conven-
ional cardiac operation as a first shot, which is getting less and less
ttractive.
Dr Chang. Thank you for your comment. That may be the best
ay to go, but our experience with pericardectomy in general
uggests that post-radiation patients account for less than 10% of
hat population.
and Cardiovascular Surgery ● Volume 133, Number 2 413
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CDABLE E1. Postoperative complications
omplication Definition
espiratory insufficiency Combination of reintubation, extended time intubated (72 h), readmission to ICU for respiratory
complications
enal failure New onset requiring hemodialysis
troke Verified by computed tomographic scan or magnetic resonance imaging, with symptoms that did not
resolve by time of discharge
yocardial infarction Intraoperative or postoperative infarction verified by electrocardiogram and enzymes (CK-MB or troponin
T)
epsis Positive blood culture results and clinical documentation
CU, Intensive care unit; CK-MB, creatine kinase MB fraction.
ABLE E2. Variables used in multivariable analyses
emographic
Female sex, age, height, weight
ancer and its treatment
Hodgkin disease, non-Hodgkin disease or lymphoma, breast cancer, lung cancer, leukemia, esophageal cancer, atrial sarcoma,
sarcoma, laryngeal/throat cancer, thymoma, testicular cancer, radiation dose, radiation booster, booster dose, chemotherapy, no.
of cancers patient had before cardiac surgery
ymptoms
New York Heart Association class, Canadian angina class, emergency operation
esting hemodynamics (at anesthesia induction)
Heart rate, mean arterial pressure, central venous pressure, pulmonary artery systolic and diastolic pressures, cardiac output
ardiac structure and function
Preoperative pleural effusion grade (0  none, 1  small, 2  moderate, 3  large); adhesions (0  none, 1  light, 2 
moderate, 3  dense); pericardial thickening (0  none, 1  mild, 2  moderate, 3  severe); pericardial calcification (0 
none, 1  mild, 2  moderate, 3  severe); mitral calcification (0  none, 1  mild, 2  moderate, 3  severe); left atrial
diameter; LV diastolic function rank; LV posterior wall thickness; intraventricular septal thickness; LV relative wall thickness; LV
mass; LV mass index; LV end-diastolic volume index; LV end-systolic volume index; LV fractional shortening; LV ejection fraction;
cause of valve disease (rheumatic, degenerative, ischemic, endocarditis); valve pathology (calcification, fibrosis, chordal and
papillary muscle pathology, restricted leaflet motion); aortic, mitral, and tricuspid valve regurgitation and stenosis (presence and
grades); aortic annulus diameter
entricular function
Graded LV dysfunction, LV ejection fraction, previous myocardial infarction
oronary artery disease
No. of coronary artery systems diseased (50%), 50% and 70% stenoses of left main coronary artery, left anterior descending
coronary artery, circumflex coronary artery, and right coronary artery
ardiac rhythm
Atrial fibrillation/flutter, complete heart block, ventricular arrhythmia
oncardiac comorbidity
Smoking; history of peripheral vascular disease, carotid disease, hypertension, diabetes (insulted treated, oral hypoglycemic diet),
renal disease, COPD, COPD with pulmonary function 75% of predicted value, COPD treated, COPD grade (mild, moderate,
severe), pulmonary hypertension, blood urea nitrogen, creatinine, bilirubin, hematocrit, cholesterol, triglycerides
rocedure
CABG; use of ITA graft (single, bilateral); number of ITA grafts; CABG performed during index operation; aortic, mitral, and tricuspid
valve repair or replacement; myocardial ischemic timeV, Left ventricular; COPD, chronic obstructive pulmonary disease; CABG, coronary artery bypass grafting; ITA, internal thoracic artery.
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CDABLE E3. Risk factors for in-hospital complications
Complication and risk factor for death Coefficient  SE P value Reliability (%)
Death
Extent of radiation* 31
Extensive 1.6 0.7 .02
Variable 0.37 1.05 .7
Longer myocardial ischemic time† 0.27 0.088 .002 71
Respiratory insufficiency
Extent of radiation* 33
Extensive 1.3 0.46 .006
Variable 0.54 0.58 .4
Higher central venous pressure‡ 0.35 0.088 .0001 78
Left circumflex system disease 1.5 0.51 .004 59
Renal failure
Extent of radiation* 6
Extensive 1.3 0.91 .2
Variable 0.44 1.1 .7
Longer myocardial ischemic time† 0.26 0.11 .02 46
Severe COPD 2.7 0.82 .0009 54
Higher BUN§ 0.36 0.13 .005 50
Sepsis
Extent of radiation* 4
Extensive 0.15 0.59 .8
Variable 0.60 0.88 .5
Longer myocardial ischemic time† 0.28 0.098 .004 73
Higher central venous pressure‡ 0.29 0.1 .005 64
Lower mean arterial pressure 3.4  1.5 .02 48
Severe COPD 1.8 0.74 .02 46
Return to OR for bleeding
Extent of radiation* 2
Extensive 0.23 0.69 .7
Variable 0.15 0.81 .9
Higher central venous pressure¶ 0.12 0.047 .008 68
1-System disease 50% 1.5 0.61 .01 46
E, Standard error; COPD, chronic obstructive pulmonary disease; BUN, blood urea nitrogen; OR, operating room. *Relative to tangential radiation. †Aortic
lamp time/80, exponential transformation. ‡Central venous pressure/10, squared transformation. §Blood urea nitrogen/20, squared transformation. Mean
rterial pressure/90, inverse transformation. ¶Central venous pressure/10, exponential transformation.
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A
CDigure E1. Example of fields used for radiation of Hodgkin dis-
ase, including the mediastinum, apices of the lung, axillae, and
eck. Lung blocks (hatched areas) are used to shield part of the
ungs during treatment, but the heart and mediastinum are in-
luded in the radiation field.13.e3 The Journal of Thoracic and Cardiovascular Surgery ● February 2007
